ArticleAmerican journal of ophthalmology2022
Race and Ethnicity Differences in Disease Severity and Visual Field Progression Among Glaucoma Patients.
Article in American journal of ophthalmology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
35 citing papers in PubMed, 53 citations in OpenAlex.
- African American patient-provider communication about glaucoma vision quality-of-life.Eye (London, England) · 2024Trial
- Visual field progression in varying severities of treated patients with primary angle closure glaucoma.Scientific reports · 2026Article
- Glaucoma Progression Detection Time Using OCT and OCTA in African and European Descendants.American journal of ophthalmology · 2026Article
- Determinants of loss to follow-up after eye-related emergency visits: A race-stratified analysis at a level I trauma center.PloS one · 2026Article
- Feasibility and performance of eye movement perimetry for glaucoma triage in Tanzania: A prospective cross-sectional study in a real-world setting.PLOS global public health · 2026Article
- Kahook Dual Blade: six-month results in uncontrolled open angle glaucoma.International journal of ophthalmology · 2026Article
- The impact of treatment modality on quality of life in glaucoma patients: findings from a clinical survey study in Augusta, GA.International ophthalmology · 2025Article
- Clinically informed semi-supervised learning improves disease annotation and equity from electronic health records: a glaucoma case study.NPJ digital medicine · 2025Article
- The Impact of Race and Ethnicity on Cataract Surgery in the Nationwide All of Us Cohort.Ophthalmic epidemiology · 2025Article
- Clinically Informed Semi-Supervised Learning Improves Disease Annotation and Equity from Electronic Health Records: A Glaucoma Case Study.Research square · 2025Article
- Outcomes of Trabeculectomy With Mitomycin C in Patients of Hispanic vs European Descent.JAMA ophthalmology · 2025Article
- Association Between Optic Nerve Head Prelaminar Schisis and Visual Field Progression in Glaucoma.American journal of ophthalmology · 2025Article
- Clinically Informed Semi-Supervised Learning Improves Disease Annotation and Equity from Electronic Health Records: A Glaucoma Case Study.medRxiv : the preprint server for health sciences · 2025Article
- Effectiveness and Safety of Mitomycin C in Deep Sclerectomy with the Esnoper Clip Implant: A Case Series Study.Journal of clinical medicine · 2025Article
- Lipids and lipid regulators in intraocular pressure homeostasis.Current opinion in pharmacology · 2025Review
- Impact of Physiological and Psychological Stress on Glaucoma Development and Progression: A Narrative Review.Medicina (Kaunas, Lithuania) · 2025Review
- Equitable artificial intelligence for glaucoma screening with fair identity normalization.NPJ digital medicine · 2025Article
- Assessment of Missing Data on Glaucoma Severity Among Participants in the NIH All of Us Research Program of the United States.Journal of glaucoma · 2025Article
- Impact of Demographics on Regional Visual Field Loss and Deterioration in Glaucoma.Translational vision science & technology · 2024Article
- Disparities in Visual Field Testing Frequency Among Subjects With Glaucoma.Translational vision science & technology · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors at 3 institutions in 2 countries.
Funding
Abstract
purposeInvestigate associations of race/ethnicity and preferred language with baseline glaucoma severity, VF test frequency and disease progression.
designRetrospective cohort study.
methodsPatients receiving VF testing at a tertiary eyecare center between 1998 and 2020 with self-identified race, ethnicity and preferred language were included. Outcome measures were VF MD and age at first visit, VF test frequency, VF MD progression.
resultsAmong 29,891 patients with VF measurements between 1998 and 2020, 55.1% were female, 71.0% self-identified as White/Caucasian, 14.0% as Black/African American, 7.4% as Asian and 6.4% as Hispanic, and 11.2% preferred a language other than English. Mean VF MD at presentation was worse among Black (-9.3±9.7 dB), Asian (-6.2±7.6 dB) and Hispanic (-8.3±9.3 dB) patients (vs. Whites [-5.5±7.3 dB, p<0.001] or non-Hispanics [-6.2±7.8 dB, p<0.001]). After controlling for age, gender and English proficiency, disparities in glaucoma severity at presentation were reduced, especially among Asian and Hispanic patients. Despite greater severity at presentation, Black patients had lower VF test frequency/person-years (1.07±0.53) compared to Whites (1.12±0.52, p=0.006) and worse VF MD progression (-0.43 dB/year, 95% CI -0.67 to -0.28, p<0.001). In contrast, Hispanics had a higher VF frequency vs. non-Hispanics (1.18±0.64 vs. 1.11±0.52, p<0.001), and no difference in VF progression (p=0.77).
conclusionsBlack, Asian and Hispanic patients had greater baseline severity vs. Whites. Unlike other groups, Black patients had a lower VF frequency vs. Whites and greater VF progression. Disparities in baseline severity were partially explained by English proficiency, especially for Asian and Hispanic patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.